This story is from May 24, 2021

Mucormycosis: Bengal faces low supply of essential drug

While cases of mucormycosis or black fungus are being reported in Bengal, the state is grappling with a very low supply of Liposomal Amphotericine-B, an essential drug to treat fungal infection in Covid-19 patients. The Union government on Saturday has made available 50 more vials of the drug to West Bengal.
Mucormycosis: Bengal faces low supply of essential drug
Picture used for representational purpose only
KOLKATA: While cases of mucormycosis or black fungus are being reported in Bengal, the state is grappling with a very low supply of Liposomal Amphotericine-B, an essential drug to treat fungal infection in Covid-19 patients. The Union government on Saturday has made available 50 more vials of the drug to West Bengal.
The demand for Liposomal Amphotericine-B started increasing after rising number of cases of black fungus were registered across states.
1x1 polls
“Till May 4-5, there was not much demand of Amphotericine-B. Companies manufacturing the anti-fungal drug had a low production. But demand started to rise from May 5. We hope that supply will increase in a week,” said Rajiv Singhal, general secretary of the All India Organisation of Chemists and Druggists.
After the increase in demand , the Centre restricted its supply to retail shops and like several other medicines, Amphotericine-B, too, was supplied directly to hospitals on need basis. According to Pinaki Dey, consultant with the ILS Hospital, Amphotericine-B has been used in cases of kala azar earlier.
Somnath Ghosh of Metro Pharmacy said that they were receiving a lot of queries for the drug.
author
About the Author
Rohit Khanna

Rohit Khanna covers sectors like government finance, economy, industry and issues related to financial crime.

End of Article
FOLLOW US ON SOCIAL MEDIA